Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract
S Wadler, S Damle, H Haynes, R Kaleya, R Schechner, R Berkenblit, R D Ladner, A Murgo
Dive into the research topics of 'Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract'. Together they form a unique fingerprint.